Jones Lang LaSalle
Pharma sales hit $602B
Global pharmaceutical sales grew 7 percent last year, to $602 billion, according to IMS Health, a market-research firm that tracks prescription-drug data.
The increase was attributed, in part, to double-digit gains in such emerging markets as China, Mexico, Russia and Turkey. However, growth was slightly slower -- 5.7 percent -- in 10 major markets, including the U.S. In fact, North America accounted for 47 percent of global sales.
The firm noted that 40 percent of total market growth was fueled by the introduction of new products launched in key markets. The number of blockbusters (those with sales exceeding the billion-dol lar level) reached 94 in 2005, compared with 36 in 2000, and included 17 new members of the billion-dol lar club.
Pharma sales hit $602B
Global pharmaceutical sales grew 7 percent last year, to $602 billion, according to IMS Health, a market-research firm that tracks prescription-drug data.
The increase was attributed, in part, to double-digit gains in such emerging markets as China, Mexico, Russia and Turkey. However, growth was slightly slower -- 5.7 percent -- in 10 major markets, including the U.S. In fact, North America accounted for 47 percent of global sales.
The firm noted that 40 percent of total market growth was fueled by the introduction of new products launched in key markets. The number of blockbusters (those with sales exceeding the billion-dol lar level) reached 94 in 2005, compared with 36 in 2000, and included 17 new members of the billion-dol lar club.
posted by Jones Lang LaSalle NJ News Blog at 9:08 AM
<< Home